Prevalence, incidence and risk factors of tamoxifen‐related non‐alcoholic fatty liver disease: A systematic review and meta‐analysis

Background & Aims Tamoxifen is associated with an increased risk of developing fatty liver. The aim of this systematic review and meta‐analysis was to evaluate the prevalence and incidence of fatty liver developed after tamoxifen treatment in breast cancer patients. Methods A systematic search o...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Liver international Ročník 40; číslo 6; s. 1344 - 1355
Hlavní autori:	Lee, Bora, Jung, Eun‐Ae, Yoo, Jeong‐Ju, Kim, Sang Gyune, Lee, Cheon‐Beom, Kim, Young Seok, Jeong, Soung Won, Jang, Jae Young, Lee, Sae Hwan, Kim, Hong Soo, Jun, Baek Gyu, Kim, Young Don, Cheon, Gab Jin
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States Wiley Subscription Services, Inc 01.06.2020
Predmet:	Body mass Body mass index Body size Breast cancer Confidence intervals Fatty liver incidence Liver Liver diseases Meta-analysis Risk analysis risk factor Risk factors Searching Systematic review Tamoxifen fatty liver incidence risk factor tamoxifen
ISSN:	1478-3223, 1478-3231, 1478-3231
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!